Sequana Medical is working on both device and drug-based approaches to dealing with fluid overload in the body.
Recently, Sequana was awarded FDA clearance for an investigational new drug application (IND) of its direct sodium removal (DSR) 2.0...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?